How to stop the disease: Cure the disease with a vaccine
In February, Dr Pramod Sharma, head of the National Institute of Health and Family Welfare, announced a vaccine was on its way.
The announcement was followed by a flurry of media coverage, with people asking questions like: What’s the point of vaccinating people if we can’t be sure the vaccine will be effective?
What are the implications of a vaccine that will never be fully tested?
What does it take to vaccinate people against the disease?
How does a vaccine work?
In the vaccine trial, researchers will work with patients to help them develop their immune systems to fight off the disease.
The vaccine is being developed at the National Institutes of Health (NIH) National Institute on Aging (NIA), which will oversee the vaccine development.
The trial is being run at a facility in New York that is known as the National Center for Immunization and Respiratory Diseases.
Dr Sharma’s announcement comes at a time when the global pandemic has become increasingly deadly.
The number of new cases is expected to rise by at least 40% in coming weeks, and as the pandemic worsens, so will the chances of developing effective vaccines to fight the disease, said Dr. Jayanthi Roy, director of the NIA.
A vaccine is one way of stopping the disease and can provide a vaccine-like immune response, said Roy.
However, the vaccines currently on the market are expensive and not as effective as the ones being developed.
The vaccine trials will take place in a controlled environment and will not involve patients, so they will not be exposed to the disease for extended periods.
To get a vaccine, patients will have to complete an initial test called a vaccination trial, which is usually done in a hospital.
The test will be repeated at various stages throughout the trial.
If the vaccine test comes back positive, the patient will be given a second dose of the vaccine.
The second dose will be administered by nurses or other healthcare workers.
Once the vaccine is given, patients who receive the vaccine can be kept up-to-date on the results of the test.
A person who has already received the vaccine may not have to take a second one.
A person can also choose to be vaccinated in their community, which can be done at any hospital, nursing home, or nursing home clinic, said Shreya Varma, assistant professor at the NIE.
The results of a vaccination test are collected at the end of the trial and then sent to the researchers.
They then evaluate whether the results are positive or negative.
The results are sent to researchers for review.
If a person is vaccinated, they are not allowed to take any other medication or supplements for a month, or can stop taking certain medications for a few days.
People can also have surgery or be given injections, which will need to be monitored.
Once the vaccine comes off the market, it is highly unlikely that anyone who has not received the first dose will receive the second dose, said Varma.
The new vaccine is expected in late 2018 or early 2019, but it may not be available to people in India until early 2020.
India has the world’s worst case of dengue fever.